Clifford R. Jack Jr

In this engaging discussion, Dr. Kevin Duff, a board-certified clinical neuropsychologist and Alzheimer’s researcher, and Dr. Clifford Jack, a leading expert in Alzheimer’s biology from Mayo Clinic, explore the latest updates in diagnosing and staging Alzheimer’s disease. They delve into the complexities of combining biological markers with cognitive assessments, the predictive validity of amyloid PET scans in asymptomatic individuals, and the evolving criteria for effective patient care. Their insights may reshape how we understand and approach Alzheimer's diagnostics, offering hope for future advancements.

Dr. Clifford R. Jack Jr, a leading Alzheimer's disease researcher from the Mayo Clinic, shares cutting-edge insights into diagnosing and staging Alzheimer’s disease. The discussion highlights the pivotal role of biomarkers, moving beyond traditional dementia symptoms. Jack emphasizes the classification of core biomarkers related to A-beta and tau proteins, advocating for their use in early intervention. He also outlines future directions that blend clinical practice with scientific advancement, aiming for improved patient care and treatment outcomes.